Clinical and laboratory findings in neurobrucellosis: review of 31 cases

ABDAM HAJI, M RASOULINEZHAD, S Jafari, M Hasibi… - 2008 - sid.ir
Background: Neuro BRUCELLOSIS is an uncommon complication of BRUCELLOSIS. The
clinical features of neuro BRUCELLOSIS vary greatly and, in general, tend to be chronic. …

Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study

…, K Alikhani, S Yadegari, S Jafarian… - Current stem cell …, 2012 - ingentaconnect.com
Despite updating knowledge and a growing number of medications for multiple sclerosis (MS),
no definite treatment is available yet for patients suffering from progressive forms of the …

High-altitude sleep disturbance: results of the Groningen Sleep Quality Questionnaire survey

S Jafarian, F Gorouhi, A Taghva, J Lotfi - Sleep medicine, 2008 - Elsevier
OBJECTIVE: To assess the Groningen Sleep Quality Scale (GSQS) for evaluation of high-altitude
sleep (HAS) disturbance and employ GSQ questionnaire to describe HAS. METHODS: …

Sumatriptan for prevention of acute mountain sickness: randomized clinical trial

S Jafarian, F Gorouhi, S Salimi… - Annals of Neurology …, 2007 - Wiley Online Library
Objective To determine the impact of sumatriptan prophylaxis on acute mountain sickness (AMS)
and altitude headache development within 24 hours of ascent, we designed a double‐…

Predictors of the chest CT score in COVID-19 patients: a cross-sectional study

…, AH Ghadery, SA SeyedAlinaghi, F Jafari, S Jafari… - Virology journal, 2021 - Springer
Background Since the COVID-19 outbreak, pulmonary involvement was one of the most
significant concerns in assessing patients. In the current study, we evaluated patient’s signs, …

Safety and effectiveness of azithromycin in patients with COVID-19: an open-label randomised trial

E Sekhavati, F Jafari, SA SeyedAlinaghi… - International journal of …, 2020 - Elsevier
As no specific pharmacological treatment has been validated for use in coronavirus disease
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …

Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial

…, M Hasannezhad, F Ghiasvand, S Jafari… - Pharmacological …, 2022 - Springer
Background and objectives Corticosteroids are commonly used in the treatment of hospitalized
patients with COVID-19. The goals of the present study were to compare the efficacy and …

[HTML][HTML] Efficacy and safety of sofosbuvir/ledipasvir in treatment of patients with COVID-19; A randomized clinical trial

…, Z Ahmadinejad, HE Kouchak, S Jafari… - Acta Bio Medica …, 2020 - ncbi.nlm.nih.gov
Background: There is no study regarding the use of SOF/LDP in treatment of COVID-19.
Objectives: In this study, the efficacy and safety of SOF/LDP were assessed in treatment of …

Molecular Epidemiology and Drug Resistance Pattern of Carbapenem-Resistant Klebsiella pneumoniae Isolates from Iran

Z Jafari, AA Harati, M Haeili… - Microbial Drug …, 2019 - liebertpub.com
The emergence and dissemination of carbapenem-resistant Klebsiella pneumoniae (CRKP)
isolates and their involvement in several nosocomial outbreaks are of high concern. This …

[HTML][HTML] The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a systematic review

…, MA Ashraf, R Roshanshad, S Jafari… - Iranian Journal of …, 2020 - ncbi.nlm.nih.gov
Materials and Methods: We performed a systematic search in Pubmed, Embase, Web of
Science, Google scholar and MedRxiv for relevant observational and interventional studies. The …